Avigen Inc., of Alameda, Calif., added Glenn Pierce as vice president, clinical development.
BioHouston Inc., of Houston, named Jacqueline Northcut president.
BioMS Medical Corp., of Edmonton, Alberta, appointed Don Kimak chief financial officer.
Bio-Technology General Corp., of East Brunswick, N.J., appointed Whitney Stearns senior vice president, chief financial officer and treasurer.
Cambrex Corp., of East Rutherford, N.J., promoted Salvatore Guccione to executive vice president, corporate strategy and development.
CellGate Inc., of Sunnyvale, Calif., appointed Thomas Wiggans to its board.
Corgentech Inc., of Palo Alto, Calif., appointed Lynn Seely vice president of clinical research.
DOR BioPharma Inc., of Lake Forest, Ill., appointed Evan Myriantholopoulos to its board.
Ecopia BioSciences Inc., of Montreal, appointed Gervais Dionne to its board.
Enanta Pharmaceuticals Inc., of Watertown, Mass., appointed Robert Kamen to its scientific advisory board.
Scios Inc., of Sunnyvale, Calif., promoted Randall St. Laurent to vice president of sales, Laura Simon to vice president of corporate planning and development and Sundeep Dugar to vice president of chemistry.
Silicon Genetics Inc., of Redwood City, Calif., appointed Kevin Wandryk as vice president of marketing and business development.
Southern Research Institute in Frederick, Md., named Brigitte Beer group leader of molecular virology, Victor Buckwold group leader of hepatitis research, Dwayne Lunsford group leader of bacteriology and Peter Silvera group leader of immunology and vaccine research.
SuperGen Inc., of Dublin, Calif., added Craig Rosenfeld as chief scientific officer.
Tensor Biosciences, of Irvine, Calif., appointed Joseph Coyle, Richard Morris, Roger Nicoll and Samuel Deadwyler to its scientific advisory board.
The Pennsylvania Biotechnology Association, of Malvern, Pa., appointed Fritz Bittenbender as president.
Tularik Inc., of South San Francisco, appointed Jack Anthony as senior vice president, business and commercial development.